Skip to main content
MACROGENICS INC logo

MACROGENICS INC — Investor Relations & Filings

Ticker · MGNX ISIN · US5560991094 LEI · 5493001KJQUA83L8MH79 US Manufacturing
Filings indexed 894 across all filing types
Latest filing 2014-03-07 Director's Dealing
Country US United States of America
Listing US MGNX

About MACROGENICS INC

https://www.macrogenics.com/

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The company utilizes its proprietary antibody engineering platforms, including the DART (Dual-Affinity Re-Targeting) and TRIDENT technologies, to create novel product candidates. Its pipeline consists of investigational treatments such as monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific antibodies. MacroGenics maintains fully-integrated capabilities, from research and discovery through to GMP (Good Manufacturing Practice) manufacturing, to advance its portfolio of potential medicines for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2014-03-07 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 5, 2014, reporting the appointment of Matthew Fust to the Board of Directors and as Chairman of the Audit Committee. The content focuses on changes in the company's board and management, detailing Mr. Fust's background, qualifications, and compensation arrangements. There are no financial statements or earnings data, nor is this a report or announcement of a report publication. The primary subject is a management change, fitting the category of Board/Management Information (MANG). The document length is 4490 characters, which is consistent with a typical 8-K filing for management changes. Therefore, the appropriate classification is MANG with high confidence.
2014-03-07 English
FORM 4 SUBMISSION
Director's Dealing
2014-02-18 English
FORM 4 SUBMISSION
Director's Dealing
2014-02-18 English
SC 13G
Major Shareholding Notification
2014-02-14 English
Major Shareholding Notification 2014
Major Shareholding Notification
2014-02-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.